A dichoptic digital therapeutic may benefit young children with amblyopia
- Posted on: Jan 24 2022
- Leave a response
In this Phase 3 randomized, controlled clinical trial, investigators evaluated the safety and efficacy of dichoptic amblyopia therapy vs. continued refractive correction alone in children aged 4 to 7 years with unilateral amblyopia caused by anisometropia and/or mild strabismus.
Source: AAO
Posted in: Uncategorized
